145 Folgen

The Foundation Fighting Blindness is committed to finding treatments and cures for blinding retinal diseases that affect more than 10 million people in the United States. To learn more, go to FightingBlindness.org.

Foundation Fighting Blindness Fnd Fighting Blindness

    • Wissenschaft

The Foundation Fighting Blindness is committed to finding treatments and cures for blinding retinal diseases that affect more than 10 million people in the United States. To learn more, go to FightingBlindness.org.

    Eye on the Cure Podcast | Episode 67: Dr. Peter Campochiaro

    Eye on the Cure Podcast | Episode 67: Dr. Peter Campochiaro

    Dr. Peter Campochiaro, a clinician-scientist and the Eccles Professor of Ophthalmology and Neuroscience at the Johns Hopkins University School of Medicine, talks to host Ben Shaberman about N-acetylcysteine (NAC), a drug that shows promise for preserving cone vision (central vision and acuity) in people with retinitis pigmentosa. The powerful antioxidant has moved into a 30+ site, Phase 3 clinical trial called NAC Attack.

    • 19 Min.
    Eye on the Cure Podcast | Episode 66: Peter Wallsten

    Eye on the Cure Podcast | Episode 66: Peter Wallsten

    Peter Wallsten, a veteran newspaper journalist and head of investigative reporting at The Washington Post, talks to host Ben Shaberman about his evolving career as a reporter and editor and the impact that Stargardt disease has had on his journey and ambitions. Peter also reflects on recently receiving a Pulitzer Prize for his team's 15-part series on the role of the AR-15 assault rifle in mass shootings and how the weapon has become one of the best-selling firearms in the US.

    • 25 Min.
    ARVO 2024 Highlight: InGel’s Cell Therapy Shows Promise for Preserving Vision

    ARVO 2024 Highlight: InGel’s Cell Therapy Shows Promise for Preserving Vision

    The emerging treatment is designed to work for people with RP and other conditions regardless of the gene mutation causing disease

    • 3 Min.
    ARVO 2024 Highlight: PYC Reports Initial Clinical Trial Results for its RNA Therapy Targeting RP

    ARVO 2024 Highlight: PYC Reports Initial Clinical Trial Results for its RNA Therapy Targeting RP

    No serious adverse events were reported. One patient had encouraging improvement in retinal sensitivity.

    • 3 Min.
    ARVO 2024 Highlight: New Gene Linked to RP in People with African Ancestry

    ARVO 2024 Highlight: New Gene Linked to RP in People with African Ancestry

    The discovery will help geneticists diagnose more RP patients with African descent.

    • 4 Min.
    ARVO 2024 Highlight: Positive Two-Year Results from PDE6B Gene Therapy Clinical Trial

    ARVO 2024 Highlight: Positive Two-Year Results from PDE6B Gene Therapy Clinical Trial

    Mutations in PDE6B are a leading cause of retinitis pigmentosa.

    • 3 Min.

Top‑Podcasts in Wissenschaft

Sternengeschichten
Florian Freistetter
Aha! Zehn Minuten Alltags-Wissen
WELT
ZEIT WISSEN. Woher weißt Du das?
ZEIT ONLINE
Ö1 Radiokolleg
ORF Ö1
Rätsel der Wissenschaft
DER STANDARD
Synapsen – ein Wissenschaftspodcast
NDR Info

Das gefällt dir vielleicht auch

Pivot
New York Magazine
The Weekly Show with Jon Stewart
Comedy Central
Freakonomics Radio
Freakonomics Radio + Stitcher
The Daily
The New York Times
On with Kara Swisher
Vox Media
Acquired
Ben Gilbert and David Rosenthal